checkAd

     113  0 Kommentare Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program - Seite 3

    CONTACT:  

    Monopar Therapeutics Inc.
    Investor Relations  
    Kim R. Tsuchimoto  
    Chief Financial Officer  
    kimtsu@monopartx.com  

    Follow Monopar on social media for updates: 

    Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics

    Lesen Sie auch

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0773bb83-f9ca-4ee3 ...



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program - Seite 3 WILMETTE, Ill., March 05, 2024 (GLOBE NEWSWIRE) - Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced positive preclinical imaging …